SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop head and neck cancer from returning
Disease control CompletedThis early-phase study tested the safety of adding the drug afatinib to standard radiation therapy (with or without chemotherapy) for people with intermediate- or high-risk head and neck cancer after surgery. Afatinib blocks proteins that help cancer grow and may make cancer cell…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:32 UTC
-
New drug combo shows promise for Tough-to-Treat cancers
Disease control CompletedThis study tested whether combining two drugs, brentuximab vedotin and pembrolizumab, can shrink tumors in people with advanced melanoma, lung cancer, or head and neck cancer that has spread. The trial included 161 participants whose cancer had not responded to prior treatments. …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 03:31 UTC
-
Last-Resort drug shows promise for tough head and neck cancers
Disease control CompletedThis study tested the drug mitomycin C in 48 adults with incurable head and neck cancer that had stopped responding to standard therapies. The goal was to see if the drug could shrink tumors. The trial focused on two groups: patients with HPV-related and HPV-unrelated cancers. Re…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New drug combo shows promise for incurable head and neck cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs (IRX-2 regimen and durvalumab) in 19 patients with advanced head and neck cancer that could not be cured with standard treatments. The main goals were to check safety and see if the drugs could boost the immune response ins…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
MRI-Guided radiation boosts hope for tough head and neck cancers
Disease control CompletedThis study tested a new way to give radiation therapy to people with advanced head and neck cancer. Doctors used a special MRI scan to find the toughest parts of the tumor and gave those areas a higher dose of radiation, while keeping standard doses to healthy tissues. The goal w…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy aims to tame head and neck cancer with fewer side effects
Disease control CompletedThis study tested a personalized three-step treatment for head and neck cancer that combines chemotherapy, surgery, and radiation. The goal was to see if this approach could reduce harmful side effects while still effectively controlling the disease. Forty adults with previously …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Immune cell combo shows promise in Tough-to-Treat head and neck cancers
Disease control CompletedThis early-phase study tested a new treatment for people with advanced head and neck cancer that has come back or spread. The treatment combines specially grown immune cells (memory-like NK cells) with drugs that help the immune system attack cancer. The main goal was to check sa…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Immunotherapy shows promise in shrinking head and neck tumors before surgery
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab (MK-3475) before standard surgery could help prevent head and neck cancer from coming back. It included 67 adults with advanced, surgically removable head and neck cancer. The main goal was to see if the drug c…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Tailored immunotherapy shows promise for tough head and neck cancers
Disease control CompletedThis study tested a personalized approach to immunotherapy in 20 people with advanced head and neck cancer that had already worsened after standard immunotherapy. Researchers used genetic testing of the tumor to choose which additional drug to add to the standard treatment, aimin…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Radiation may supercharge immunotherapy in advanced cancers
Disease control CompletedThis study tested whether giving a short course of radiation to one tumor site within two weeks of starting immunotherapy could help the immune system fight cancer better. It included 76 adults with advanced lung or head/neck cancers who were already eligible for standard immunot…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New cocktail of drugs shows promise against tough head and neck cancer
Disease control CompletedThis study tested several drug combinations in 12 people with advanced head and neck cancer that had not been treated yet. The goal was to see if the drugs could make the tumors disappear before surgery. The study is complete, and results help guide future treatment options.
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New study aims to reduce dry mouth from head and neck cancer radiation
Symptom relief CompletedThis study looked at two different ways to plan radiation therapy for head and neck cancer to see which causes less dry mouth. 23 patients were randomly assigned to either a standard margin-based plan or a robust plan. The goal was to improve quality of life by reducing this comm…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
Home diet help boosts cancer Patients' Well-Being
Symptom relief CompletedThis study looked at whether having a dietitian visit patients at home during radiation therapy could improve their overall quality of life. The study included 117 adults with head and neck cancer who were receiving radiation, with or without chemotherapy. The main goal was to se…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated May 05, 2026 11:52 UTC
-
New study explores the hidden struggles of head and neck skin cancer patients
Knowledge-focused CompletedThis study looked at how people with a serious type of skin cancer on the head or neck feel about their treatment choices, their quality of life, and their care. Researchers asked 78 patients to fill out questionnaires. The goal was to learn more about their experiences, not to t…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC